EX-10.3 4 rcel-ex10_3.htm EX-10.3 EX-10.3

Exhibit 10.3

HHSO100201500028C P00015 Page 3 of 4

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT BOTH (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

 

The purpose of this modification is to add and fund CLINS 0011, 0012, & 0013.

 

ARTICLE B.3. OPTION PRICES is hereby modified as follows:

 

CLIN

Period of Performance

Supplies/ Services

Units (# of Product)

 

Unit Price ($)

Total ($)

 

 

FIRM FIXED PRICE

 

 

 

0003 (Option)

36 Months

Phase IV post marketing commitments /Requirements (This is an option that may or may not be exercised during the base period as determined by the need and as established by the FDA)

N/A

N/A

$[******] (Not Funded)

0009

09/29/2015 – 09/28/2022

FY 2016/FY2017 Final Rate True Up

N/A

N/A

$[******] (Funded)

0010

09/29/2015 – 09/28/2022

FY 2017/FY2018 Final Rate True Up

N/A

N/A

$[******] (Funded)

0011

02/16/2024 – 09/28/2025

VMI Maintenance Tasks

N/A

N/A

$[******]

(Funded)

0012

02/16/2024 – 09/28/2025

VMI Procurement

1000

$4,500

$[******]

(Funded)

0013

02/16/2024 – 09/28/2025

Additional VMI Ramp

1103

$6,500

$[******] (Funded)

 

 

COST REIMBURSEMENT

 

 

 

0004 (Option Exercised)

09/18/2017 – 09/28/2025

Pediatric Study (This is an option that may or may not be exercised during the base period for expansion of the label indication with guidance from the FDA)

$[******]

$[******]

$[******] (Funded)

 

 

FIRM FIXED PRICE

 

 

 

0005 (Option)

36 Months

Additional Surge Capacity

[******]

$[******]

$[******] (Ceiling – Not Funded)

0006 (Option)

36 Months

Additional Surge Capacity

[******]

$[******]

$[******] (Ceiling – Not Funded)

0007 (Option)

36 Months

Additional Surge Capacity

[******]

$[******]

$[******] (Ceiling – Not Funded)

0008 (Option)

36 Months

Additional Surge Capacity

[******]

$[******]

$[******] (Ceiling – Not Funded)

Exhibit 10.3

HHSO100201500028C P00015 Page 4 of 4

Total Unfunded Option CLINs 3, 5-8

60 Months

See Above Descriptions

 

 

$[******]  (Not Funded)

Total Funded Option CLINs 4, 9-13

See Above

See Above Descriptions

 

 

$[******]  (Funded)

 

 

ARTICLE B.5. ADVANCE UNDERSTANDINGS Paragraph l.8 is deleted and replaced in its entirety:

 

l.
Additional Understandings
8.
It shall be noted that effective as of Modification P00015, there will be no other reporting requirements within this contract beyond what is described in the SoW.

 

 

SECTION J - LIST OF ATTACHMENTS

 

The following documents are attached and incorporated in this contract:

 

1.
Statement of Work, dated Feb 13, 2024, 4 pages

 

End of Modification #15